ILD Day 2026 Spotlights Precision Medicine's Potential to Transform Patient Care
CHICAGO, Aug. 20, 2026 — The emerging role of precision medicine in diagnosing and treating interstitial lung disease will take center stage during the sixth annual ILD Day on Wednesday, Sept. 16.
Interstitial lung disease, or ILD, refers to a group of lung diseases that cause inflammation, scarring or both. More than 250,000 Americans are living with pulmonary fibrosis and other interstitial lung diseases.
“Brad and Krishna bring invaluable expertise to the PFF at a pivotal time for the organization,” said Wayne Pan, MD, PhD, MBA, Chair of the PFF Board of Directors. “Their clinical leadership, research accomplishments and patient-centered approach will strengthen our Board as we work to expand the impact of our programs and implement our strategic plan.”
"Research is helping us better understand ILD and how it may affect each person differently," said Amy Hajari Case, MD, Chief Medical Officer of the Pulmonary Fibrosis Foundation. "As the science moves forward, it is just as important to make sure patients and families can find clear information, trusted resources and the support they need. ILD Day brings those pieces together."
Designed for patients, caregivers and healthcare professionals, the webinar will explain the science behind precision medicine in an accessible and practical way. It will also examine how these advances may influence the future of ILD diagnosis, treatment and long-term disease management.
Because many forms of ILD are progressive, early detection and an accurate diagnosis are critical to managing the disease. Depending on the type and severity of ILD, treatment may include medication, lifestyle changes, supplemental oxygen and, in advanced cases, lung transplantation.
On ILD Day, 13 organizations representing people affected by ILD and related conditions come together to raise awareness, share the developments in care and amplify the voices of patients and families.
ILD Day is held each September as part of Pulmonary Fibrosis Awareness Month, which brings greater attention to pulmonary fibrosis and its place within the broader group of interstitial lung diseases.
To register for the free webinar and learn more about ILD Day, visit ILDDay.org.
About ILD Day
ILD Day is presented annually by a collaboration of 13 organizations representing patients affected by interstitial lung disease: Arthritis Foundation, Foundation for Sarcoidosis Research, The Myositis Association, The Myositis Clinical Trials Consortium, National Scleroderma Foundation, Nori's Fight, PF Warriors, Pulmonary Fibrosis Foundation, Scleroderma Foundation of Greater Chicago, Scleroderma Research Foundation, Sjögren's Foundation, Team Telomere and Wescoe Foundation for Pulmonary Fibrosis. For more information, visit ILDDay.org.
About the Pulmonary Fibrosis Foundation
The Pulmonary Fibrosis Foundation is committed to accelerating research, empowering our community, and transforming care so that everyone with pulmonary fibrosis can live a better life. Our ultimate goal is to find a cure for pulmonary fibrosis. The PFF has a four-star rating from Charity Navigator and is an accredited charity by the Better Business Bureau (BBB) Wise Giving Alliance. The Foundation has met all of the requirements of the National Health Council Standards of Excellence Certification Program® and has earned the Guidestar Platinum Seal of Transparency. For more information, visit pulmonaryfibrosis.org or call 844.TalkPFF (844.825.5733)